Wealth Enhancement Advisory Services LLC Has $61.40 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Wealth Enhancement Advisory Services LLC lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 7.1% in the third quarter, Holdings Channel.com reports. The fund owned 151,076 shares of the company’s stock after selling 11,578 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in HCA Healthcare were worth $61,402,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. CreativeOne Wealth LLC bought a new position in HCA Healthcare during the first quarter worth about $231,000. New Mexico Educational Retirement Board grew its holdings in shares of HCA Healthcare by 29.9% in the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after purchasing an additional 3,200 shares during the last quarter. Bessemer Group Inc. lifted its holdings in HCA Healthcare by 51.2% during the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after purchasing an additional 2,584 shares during the last quarter. Empowered Funds LLC increased its holdings in shares of HCA Healthcare by 54.3% during the first quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock worth $4,639,000 after buying an additional 4,893 shares in the last quarter. Finally, Swedbank AB acquired a new position in shares of HCA Healthcare in the 1st quarter worth approximately $95,882,000. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the transaction, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,345 shares of company stock valued at $5,747,945. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

HCA opened at $363.55 on Friday. HCA Healthcare, Inc. has a 12 month low of $220.55 and a 12 month high of $417.14. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The stock has a market cap of $93.82 billion, a P/E ratio of 17.07, a P/E/G ratio of 1.52 and a beta of 1.67. The company has a fifty day simple moving average of $395.06 and a 200 day simple moving average of $352.71.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.73%. HCA Healthcare’s payout ratio is 12.39%.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. KeyCorp began coverage on HCA Healthcare in a research report on Friday, October 11th. They issued an “overweight” rating and a $475.00 price objective for the company. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Wells Fargo & Company increased their price target on shares of HCA Healthcare from $365.00 to $395.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 22nd. Royal Bank of Canada upped their price objective on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Finally, Oppenheimer boosted their target price on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, twelve have issued a buy rating and four have issued a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $377.17.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.